Blue Horseshoe Stocks: Options Review


Options Review

We dedicated yesterday’s premarket newsletters to our Special Report, so we wanted to circle back this morning to go over a couple of options ideas we submitted to our readers on Tuesday morning.

We had identified plays in the ULTA and MKC options chains following a Form-4 Alert and an earnings report, respectively, and in both cases we met with fantastic multi-bag gain opportunities. Here were the total possible profits on the table:

ULTA 11/01 $260-265 Calls
$260 Calls – Range: 4.00-13.30 – Max Gain: 233%
$262.50 Calls – Range: 2.60-12.50 – Max Gain: 381%
$265 Calls – Range: 2.80-11.25 – Max Gain: 302%
_____

MKC Weekly $155-160 Calls

$155 Calls – Range: 5.58-13.58 – Max Gain: 143%
$160 Calls – Range: 2.82-9.12 – Max Gain: 223%
_____

Fresh Options Idea:
PEP Weekly $134-136 Calls 



American Renal Associates Holdings, Inc. ARA

We also want to place ARA on watch as a possible bottom bounce play. The stock has never been much lower than where it’s currently trading, has a recently history of sharp spikes, and indications that a significant rebound could be on the way. We’ll keep an eye peeled for such activity over the next several sessions.


Extended Watchlist:
CBNT, CLVS, ARQL, BIOC, HYRE, MEET

Blue Horseshoe Stocks: Playing the SPY

Friday Options Review

Coty, Inc. COTY- Among our fresh options ideas in Friday morning’s report was a range of contracts in the COTY chain, and from that, came the opportunity for ourselves and our readers to log some very impressive daily profits.

Our targets were the Coty, Inv. COTY Weekly $8-9 Calls, and all three of those contract sets produced multi-bag intraday days for us.

$8 Calls – Range: .56-1.35 – Max Gain: 141%
$8.50 Calls – Range: .22-.83 – Max Gain: 277%
$9 Calls – Range: .05-.34 – Max Gain: 580%
_____

SPDR S&P 500 ETF (SPY) Weekly $270.50-269 Puts

We were also entertaining a range of Puts in the SPY chain, as it appeared the markets wanted to begin the session in bearish fashion. That certainly proved to be the case, as the first half of the session saw a significant backslide prior to a late afternoon recovery to finish the day flat.

That activity allowed for a good showing from three of the four contracts in our highlighted range, the SPY Weekly $270.50-269 Puts. While the potential windfalls weren’t as extreme as the aforementioned play, they still each recorded a multi-bag move on the day.

$270 Calls
 – Range: 1.00-2.20 – Max Gain: 120%
$269.50 Calls – Range: .71-1.70 – Max Gain: 139%
$269 Calls – Range: .49-1.35 – Max Gain: 176%

Fresh Idea:
Now that we’re seeing a bit of a bounceback which figures to lead to a higher open this morning, we’ll go ahead and shift our early focus today on the SPY 02/11 $271-272 Calls. These expire today, and therefore must be treated like a weekly option on a Friday. It’s a risky proposition. Expert level traders only!


Extended Watchlist:
CNHC, COTE, DRVD, NGL, RARX, YRIV, RGSE, NSP, MARA, BIOC

Blue Horseshoe Stocks: GSK Recap & More

GlaxoSmithKline plc GSK – Update

We attempted to keep our excellent 2019 options performance intact yesterday, and we did see some chances for intraday gains in the fresh idea for GSK we included in our premarket report.

The stock didn’t skyrocket by any means, rising by less than a dollar, but the activity was sufficient to produce the following moves in our designated contracts.

$39.50 Calls – Range: .65-1.24 – Max Gain: 91%
$40 Calls – Range: .15-.75 – Max Gain: 400%
$40.50 Calls – Range: .10-.40 – Max Gain: 300%
_____

Fresh Idea:
GRUB Weekly $86-87.50 Calls


Calix, Inc. CALX &
Vanda Pharmaceuticals, Inc. VNDA

We want to group these two stocks together this morning and tag them as bottom-watch plays. We’ll observe for the establishment of higher lows after their recent selloffs.

Both are now in the position of being extremely oversold, and exhibiting many of the conditions we routinely look for in potential recovery plays. We’ll observe their activity as we head into the end of the week.


Extended Watchlist:
DRVD, PYDS, NVCN, TPNL, BIOC